RESOLUTE ONYX China RCT Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 550 participants.
Also called NCT03466151
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 550 participants
- Sponsor
- Registry
-
NCT03466151
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03466151. Randomized; no masking; primary purpose treatment. Start 2018-04-12 (actual); primary completion 2021-02-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- RESOLUTE ONYX China RCT Study
- Condition
- Ischemic Heart Disease
- Condition
- Stenotic Coronary Lesion
- Condition
- Cardiovascular Diseases
- Condition
- Arteriosclerosis
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
- Intervention (Device)
- Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System
- Lead sponsor
- Medtronic Vascular
Record details
- Record id
cardio:ct-nct03466151- Content hash
13aa7609b1535dea4b6cb25867e0d35b3e09da0274aa1707b8118ff59621c6f8